# Analgesia in Minimally Invasive Direct Coronary Artery Bypass Grafting: Programmed Intermittent Bolus Infusions of Erector Spinae Plane Block Versus Paravertebral Block

> **NCT05320718** · NA · COMPLETED · sponsor: **Peking University Third Hospital** · enrollment: 140 (actual)

## Conditions studied

- Regional Anesthesia
- Anesthesia, Local
- Surgery

## Interventions

- **DRUG:** Ropivacaine

## Key facts

- **NCT ID:** NCT05320718
- **Lead sponsor:** Peking University Third Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-04-15
- **Primary completion:** 2023-04-30
- **Final completion:** 2023-12-30
- **Target enrollment:** 140 (ACTUAL)
- **Last updated:** 2026-04-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05320718

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05320718, "Analgesia in Minimally Invasive Direct Coronary Artery Bypass Grafting: Programmed Intermittent Bolus Infusions of Erector Spinae Plane Block Versus Paravertebral Block". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05320718. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
